Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=170"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=170

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT04234698-669154e6",
        "title": "Warfarin vs NOACs: Number of Participants With Intracranial Bleeding",
        "summary": "5 of 459 against 2 of 1617; risk difference 1.0 points, 95% interval 0.3 to 2.4; NCT04234698, Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia",
        "record": "/library/comparisons/NCT04234698-669154e6",
        "nct_id": "NCT04234698",
        "kind": "outcome",
        "participants": 2076,
        "risk_difference": {
          "value": 0.009656387807648312,
          "lower": 0.002622772925326946,
          "upper": 0.02403491545735541
        },
        "group_1": "5 of 459",
        "group_2": "2 of 1,617",
        "difference": "1.0 points",
        "interval": "0.3 to 2.4",
        "trial_title": "Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia"
      },
      {
        "id": "NCT04234698-8d7d439c",
        "title": "Warfarin vs NOACs: Number of Participants With Uncontrolled Hypertension at OAC Prescription Date",
        "summary": "19 of 459 against 50 of 1617; risk difference 1.0 points, 95% interval -0.7 to 3.4; NCT04234698, Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia",
        "record": "/library/comparisons/NCT04234698-8d7d439c",
        "nct_id": "NCT04234698",
        "kind": "outcome",
        "participants": 2076,
        "risk_difference": {
          "value": 0.010472876019094506,
          "lower": -0.007121147579337173,
          "upper": 0.03401145012153374
        },
        "group_1": "19 of 459",
        "group_2": "50 of 1,617",
        "difference": "1.0 points",
        "interval": "-0.7 to 3.4",
        "trial_title": "Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=171",
  "request_id": "6t3Mvg1A1T9xS6HL"
}